Locus Bioscience
  • Home
  • About Us
  • Platforms
  • Programs
  • Careers
  • Media
Contact

Media

Learn more about us in our featured news stories and insights into the work that we do.

News Press Releases Locus Insights

Posts navigation

1 2 3 … 7 Next
  • September 13, 2022

    Locus Biosciences Announces First Patient Treated in the ELIMINATE Registrational Phase 2/3 Trial of LBP-EC01 for Urinary Tract Infections

    Learn More
  • May 20, 2022

    J&J backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3

    Learn More
  • May 18, 2022

    RTP’s Locus Biosciences closes $35M Series B, investors include J&J and Tencent

    Learn More
  • May 18, 2022

    Locus Biosciences Announces $35 Million Financing

    Learn More
  • April 6, 2022

    Bacteriophages

    Learn More
  • April 4, 2022

    Bacteriophage (Phage) Therapy

    Learn More
  • April 3, 2022

    Locus Biomanufacturing Solutions Facility

    Learn More
  • April 2, 2022

    Urinary Tract Infections

    Learn More
  • March 23, 2022

    Locus’ Pac-Man-like precision medicine could negate antibiotic collateral damage

    Learn More
  • March 4, 2022

    The transformation of precision medicine in infectious disease

    Learn More
  • Posts navigation

    1 2 3 4 … 7 Next

Careers

We are on a mission to revolutionize the treatment of disease. We need intelligent, open, hard-working people who thrive in a fast-paced environment to join us on our quest.

Join Our Team

Media Inquiries


For all media inquiries, please contact
our public relations agency below

Contact Now
Locus Biosciences

Precision Medicines for Bacterial Infections
and Microbiome Diseases

Home

About Us

Platforms

Programs

Careers

Media

Contact

Location

523 Davis Drive Suite 350
Morrisville NC 27560

Email

info@locus-bio.com

Linkedin

Linkedin

Twitter

Twitter

©Copyright 2022 Locus Biosciences, Inc. All rights reserved.

powered by wildfire